SCHEMBL699491

SCHEMBL699491

CC(C)(C)c1cc(C=C(CCOCCOCCC(=Cc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)C(=O)O)C(=O)O)cc(C(C)(C)C)c1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 2/20 0.48
GABBR1 Q9UBS5 2/20 0.48
HMGCR P04035 2/20 0.46
GPR55 Q9Y2T6 1/20 0.46
NR1I2 O75469 1/20 0.46
EGFR P00533 1/20 0.44
CYP1A2 P05177 3/20 0.43
CYP2C9 P11712 3/20 0.43
MEN1 O00255 3/20 0.43
CYP3A4 P08684 3/20 0.43
MAPT P10636 3/20 0.43
TSHR P16473 3/20 0.43
BLM P54132 3/20 0.43
KMT2A Q03164 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
HSD17B10 Q99714 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
RGS12 O14924 2/20 0.43
GMNN O75496 2/20 0.43
ALDH1A1 P00352 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11096689 0.84 GABBR2 (0.51) GABBR2GABBR1HMGCRGPR55NR1I2
SCHEMBL10682355 0.84 GABBR2 (0.51) GABBR2GABBR1HMGCRGPR55NR1I2
SCHEMBL699097 0.84 GABBR2 (0.51) GABBR2GABBR1HMGCRGPR55NR1I2
SCHEMBL11096685 0.84 GABBR2 (0.51) GABBR2GABBR1HMGCRGPR55NR1I2
SCHEMBL696525 0.82 GABBR2 (0.49) GABBR2GABBR1HMGCRGPR55NR1I2
SCHEMBL10967937 0.81 GABBR2 (0.54) GABBR2GABBR1HMGCRGPR55NR1I2
SCHEMBL10494818 0.81 GABBR2 (0.54) GABBR2GABBR1HMGCRGPR55NR1I2
SCHEMBL5847331 0.81 GABBR2 (0.48) GABBR2GABBR1HMGCRGPR55NR1I2
SCHEMBL5710763 0.81 GABBR2 (0.48) GABBR2GABBR1HMGCRGPR55NR1I2
SCHEMBL180578 0.80 GABBR2 (0.47) GABBR2GABBR1HMGCRGPR55NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240166672-A1 PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-05-23 US disclosed
EP-4371988-A1 PHENOLIC COMPOUND, ORGANIC MATERIAL STABILIZER, RESIN COMPOSITION, AND METHOD FOR STABILIZING ORGANIC MATERIAL Sumitomo Chemical Company, Limited (JP) 2024-05-22 EP disclosed
WO-2023166978-A1 PROCESS STABILIZER, ORGANIC MATERIAL COMPOSITION, AND METHOD FOR STABILIZING ORGANIC MATERIAL 住友化学株式会社 2023-09-07 WO disclosed
WO-2023286616-A1 PHENOLIC COMPOUND, ORGANIC MATERIAL STABILIZER, RESIN COMPOSITION, AND METHOD FOR STABILIZING ORGANIC MATERIAL 住友化学株式会社 2023-01-19 WO disclosed
EP-3257858-B1 PHOSPHOROUS ACID COMPOUND, METHOD FOR PRODUCING SAID COMPOUND, AND USE OF SAID COMPOUND SUMITOMO CHEMICAL CO (JP) 2020-08-26 EP disclosed
EP-3260461-B1 PHOSPHITE COMPOUND, METHOD FOR PRODUCING THE SAME AND USES THEREOF SUMITOMO CHEMICAL CO (JP) 2019-10-16 EP disclosed
US-10150857-B2 Phosphorous acid compound, method for producing said compound, and use of said compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-12-11 US disclosed
US-9902747-B2 Phosphite compound, method for producing the same and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-02-27 US disclosed
US-20180016417-A1 PHOSPHOROUS ACID COMPOUND, METHOD FOR PRODUCING SAID COMPOUND, AND USE OF SAID COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-01-18 US disclosed
US-20180002359-A1 PHOSPHITE COMPOUND, METHOD FOR PRODUCING THE SAME AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-01-04 US disclosed
US-6046261-A STABILIZER FOR ORGANIC MATERIAL HAVING EXCELLENT BLOOMING RESISTANCE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-04-04 US disclosed
US-5914361-A IMPART HEAT STABILITY TO ORGANIC MATERIALS, INCLUDING POLYOLEFINS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1999-06-22 US disclosed
US-5902516-A STABILIZER FOR THERMOPLASTIC POLYOLEFIN OR ENGINEERING RESINS SUMITOMO CHEMICAL CO., LTD (JP) 1999-05-11 US disclosed
US-5891939-A POLYMER STABILIZERS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1999-04-06 US disclosed
US-5889095-A OXYGEN AND HEAT RESISTANCE SUMITOMO CHEMICAL COMPANY, LTD. (JP) 1999-03-30 US disclosed
US-5874494-A DETERIORATION STABILIZER FOR THERMOPLASTIC RESIN; OXIDATION RESISTANCE, DISCOLORATION INHIBITION, HEAT RESISTANCE, CROSSLINKING INHIBITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1999-02-23 US disclosed
US-5847187-A Organic phosphorous compound, a process for producing the same and a use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-12-08 US disclosed
US-5830936-A THERMAL STABILIZERS FOR POLYOLEFINS AND ENGINEERING PLASTICS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-11-03 US disclosed
EP-0861847-A2 Stabilizer composition and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-09-02 EP disclosed
EP-0823435-A2 Phosphites, process for producing the same and their use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-02-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180002359-A1 PHOSPHITE COMPOUND, METHOD FOR PRODUCING THE SAME AND USES THEREOF PHOSPHO1, AGPS, PLCG1 GABBR2 4437/4885GABBR1 4562/4885HMGCR 3365/4885
US-20240166672-A1 PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME EBPL, ACSL6, ACSL3 GABBR2 4510/4885GABBR1 4645/4885HMGCR 1642/4885
US-10150857-B2 Phosphorous acid compound, method for producing said compound, and use of said compound ACSL6, ACSL3, ADSL GABBR2 4281/4885GABBR1 4531/4885HMGCR 1536/4885
US-20180016417-A1 PHOSPHOROUS ACID COMPOUND, METHOD FOR PRODUCING SAID COMPOUND, AND USE OF SAID COMPOUND ACSL6, ACSL3, ADSL GABBR2 4281/4885GABBR1 4531/4885HMGCR 1536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.